Toby Briskin

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial

Raburn M. Mallory, Neil Formica, Susan Pfeiffer et al. · The Lancet Infectious Diseases · 2022 · 81 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Long-term efficacy and immunogenicity of Ad26.RSV.preF–RSV preF protein vaccine (CYPRESS): a randomised, double-blind, placebo-controlled, phase 2b study

Ann R. Falsey, Tessa Hosman, Arangassery Rosemary Bastian et al. · The Lancet Infectious Diseases · 2024 · 27 citations

Veterinary Medicine, Immunology, Infectious Diseases +12

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults

Deborah Theodore, Angela R Branche, Lily Zhang et al. · JAMA Network Open · 2023 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Evaluating the User Performance and Experience with a Re-Engineered 4 mm × 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles

Shahista Whooley, Toby Briskin, Michael A. Gibney et al. · Diabetes Therapy · 2019 · 13 citations · Full text

Medicine, Biomedical Engineering, Surgery +17